|
Procedural Shortcomings at Novalung Plant Prompt Warning Letter
Lax documentation of testing failures and inadequate design history files for Novalung’s surgical Lung Assist device has resulted in an FDA warning letter for the German company.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives